The Form 4 filing, an SEC report of an insider’s stock trades, was filed on October 13, 2026. It lists two sales dated October 9, 2026. Both sales appear in this single filing.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-09 |
| Date of Latest Transaction | 2026-10-09 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 525,991 |
| Price | $0.95 |
| Total Transaction Value | $499,691.45 |
| Insider | |
| Ticker Symbol | OCGN |
| Company | Ocugen, Inc. |
| Insider Name | Musunuri Shankar |
| Insider Title | Chief Executive Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 5,049,241 |
| Position Size Change | 9.43% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were two sales of OCGN shares by Musunuri Shankar, Ocugen’s chief executive officer. The transactions carry code S, which identifies a sale.
What was the average price of the transaction?
The reported average price was $0.95 per share across the two sales. Separate prices for each sale are not available in the transaction details.
How did this transaction affect the insider's holdings?
He sold 525,991 shares and reported owning 5,049,241 shares afterward. The shares sold made up 9.43% of his reported holdings before the sales.
What's the total transaction value?
The two sales had a total reported value of $499,691.45.
Are there any special circumstances around this transaction?
The filing information includes a Rule 10b5-1 reference. This refers to a trading plan that sets instructions in advance. No footnote text is available to confirm whether the reference covers both sales. The plan’s start date and trading schedule are also unknown. The reference alone does not explain why the shares were sold.
For research purposes only; not investment advice.